etoposide has been researched along with Leukemia, T-Cell in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 12 (48.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abujamra, AL; Brunetto, AL; dos Santos, MP; Roesler, R; Schwartsmann, G | 1 |
| Suzuki, R | 1 |
| Arima, N; Furukawa, T; Hachiman, M; Hamada, T; Kofune, H; Kozako, T; Matsushita, K; Nakashima, M; Suzuki, S; Uozumi, K; White, Y; Yoshimitsu, M | 1 |
| Amir, R; Bernt, KM; Gaedicke, G; Hagemeier, C; Huebener, N; Jikai, J; Lange, B; Lode, HN; Niethammer, AG; Reisfeld, RA; Schroeder, U; Shabat, D; Wenkel, J; Wiebusch, L; Wrasidlo, W | 1 |
| Borst, J; de Vries, E; Eldering, E; Tait, SW; Werner, AB | 1 |
| Kobayashi, S | 1 |
| Chang, PY; Miyamoto, S | 1 |
| Enomoto, R; Hirano, H; Lee, E; Maeda, K; Miyauchi, A; Ohashi, T; Ohno, M; Sugahara, C; Suzuki, C; Tanimoto, E; Yokoi, T | 1 |
| Ishizaki, T; Itoyama, T; Kuriyama, K; Nakamura, H; Sadamori, N; Soda, H; Tomonaga, M; Yamada, Y; Yoshida, Y | 1 |
| Ishitsuka, K; Kuwazuru, Y; Makino, T; Ohno, N; Saito, T; Shimotakahara, S; Takatsuka, Y; Takeshita, T; Uozumi, K; Utsunomiya, A | 1 |
| Abe, T; Hori, M; Kojima, H; Miwa, M; Nagasawa, T; Shibuya, A | 1 |
| Konaka, Y; Namiuchi, S | 1 |
| Catchpoole, DR; Stewart, BW | 1 |
| Borsellino, N; D'Alessandro, N; Flandina, C; Flugy, A | 1 |
| Ezoe, A; Kohda, K; Kuga, T; Matsumoto, S; Mochizuki, C; Nakazawa, O; Niitsu, Y; Nobuoka, A; Watanabe, N | 1 |
| Antoku, K; Johnson, DE; Liu, Z | 1 |
| Behm, FG; Chen, CL; Fuscoe, JC; Goorha, RM; Mathew, S; Neale, GA; Relling, MV; Woo, MH | 1 |
| Hannun, YA; Obeid, LM; Reedy, MC; Zhang, J | 1 |
| Kawaguchi, M; Nakamura, A; Tsurusawa, M | 1 |
| Billio, A; Coser, P; Fabris, P; Pescosta, N; Rosanelli, C | 1 |
| Huismans, DR; Pieters, R; Schuurhuis, GJ; Styczynski, J; Veerman, AJ; Wysocki, M | 1 |
| Cullen, KV; Davey, MW; Davey, RA | 1 |
| Alvarez, E; García, MG; Hajos, SE; Lopes, EC; Vellón, L | 1 |
| Honda, J; Imamura, Y; Naito, K; Nakamura, E; Natori, H; Oizumi, K; Osabe, S; Sakamoto, A; Tanaka, K; Yosida, K | 1 |
| Nishizaki, H; Sumida, M | 1 |
2 review(s) available for etoposide and Leukemia, T-Cell
| Article | Year |
|---|---|
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Leukemia, T-Cell; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Treatment Outcome | 2010 |
Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cyclophosphamide; Etoposide; Humans; Karyotyping; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Male; Neoplasms, Second Primary; Translocation, Genetic | 1994 |
1 trial(s) available for etoposide and Leukemia, T-Cell
| Article | Year |
|---|---|
[Utility of daily oral administration of etoposide in 25 cases of refractory hematological malignancies].
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Stomatitis; Survival Analysis; Vomiting; Waldenstrom Macroglobulinemia | 1997 |
22 other study(ies) available for etoposide and Leukemia, T-Cell
| Article | Year |
|---|---|
Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells.
Topics: Antineoplastic Agents; Bleomycin; Butyrates; Cell Proliferation; Cytarabine; Doxorubicin; Drug Synergism; Etoposide; Humans; Jurkat Cells; Leukemia, T-Cell; Methotrexate; T-Lymphocytes; Vincristine | 2009 |
Novel cytotoxic isolated from Jamaican Hyptis verticillata jacq induces apoptosis and overcomes multidrug resistance.
Topics: Antineoplastic Agents; Apoptosis; Cytotoxins; Dioxolanes; DNA Damage; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Human T-lymphotropic virus 1; Humans; Hyptis; Leukemia, T-Cell; Lignans; Mitoxantrone; Plant Extracts; Poly(ADP-ribose) Polymerases; Topoisomerase Inhibitors | 2011 |
Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Hydrolysis; Inhibitory Concentration 50; Leukemia, T-Cell; Mice; Mice, Inbred Strains; Prodrugs; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
Requirement for aspartate-cleaved bid in apoptosis signaling by DNA-damaging anti-cancer regimens.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspartic Acid; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase 2; Caspase 8; Caspase 9; Caspases; Cell Line; Cytochromes c; Cytoplasm; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Etoposide; Flow Cytometry; Gamma Rays; Genes, Dominant; Granzymes; Humans; Immunoblotting; Jurkat Cells; Leukemia, T-Cell; Liver; Mice; Mitochondria; Models, Biological; Mutation; Retroviridae; RNA, Small Interfering; Serine Endopeptidases; Signal Transduction; Tumor Suppressor Protein p53; Up-Regulation | 2004 |
Colonic T-cell leukemia mimicking colon carcinoma.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma; Colectomy; Colonic Neoplasms; Diagnosis, Differential; Disease Progression; Etoposide; Humans; Leukemia, T-Cell; Male | 2005 |
Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Cycle; Cell Survival; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase Inhibitor p21; Dimerization; DNA; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Etoposide; Gene Expression Regulation, Leukemic; Humans; Immunoprecipitation; Leukemia, T-Cell; NF-kappa B; NF-kappa B p50 Subunit; Transcription Factor RelA; Transcription Factors; Transfection; Tumor Cells, Cultured | 2006 |
Wogonin, a plant flavone, potentiates etoposide-induced apoptosis in cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Drug Synergism; Etoposide; Flavanones; HL-60 Cells; Humans; Jurkat Cells; Leukemia, Promyelocytic, Acute; Leukemia, T-Cell; Rats; Scutellaria | 2007 |
[Oral administration of low-dose etoposide for maintenance chemotherapy in adult T cell leukemia patients].
Topics: Administration, Oral; Adult; Aged; Etoposide; Female; Humans; Leukemia, T-Cell; Male; Middle Aged; Remission Induction; Survival Rate | 1994 |
Successful treatment of a patient with adult T-cell leukemia by daily oral administration of low-dose etoposide. Decrease in the amount of HTLV-I proviral DNA revealed by the polymerase chain reaction method.
Topics: Administration, Oral; Aged; Base Sequence; DNA, Viral; Etoposide; Female; Human T-lymphotropic virus 1; Humans; Leukemia, T-Cell; Molecular Sequence Data; Polymerase Chain Reaction; Proviruses | 1993 |
[Extramedullary blast crisis of mixed precursor T lymphoblastic and myeloblastic features in a patient with chronic myelogenous leukemia successfully treated with low-dose oral etoposide].
Topics: Administration, Oral; Blast Crisis; Bone Marrow; Etoposide; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, T-Cell; Lymph Nodes; Male; Mediastinal Neoplasms; Middle Aged; Remission Induction; T-Lymphocytes | 1993 |
Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
Topics: Apoptosis; Cell Membrane Permeability; Cell Survival; DNA; DNA Damage; Etoposide; Flow Cytometry; Humans; Leukemia, T-Cell; Trypan Blue; Tumor Cells, Cultured | 1993 |
Development and partial characterization of a human T-lymphoblastic leukemic (CCRF-CEM) cell line resistant to etoposide. Analysis of possible circumventing approaches.
Topics: Antineoplastic Agents, Phytogenic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Leukemia, T-Cell; Tumor Cells, Cultured | 1996 |
Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents.
Topics: Antineoplastic Agents; Apoptosis; Caspase 1; Cisplatin; Cysteine Endopeptidases; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Lamin Type B; Lamins; Leukemia, T-Cell; Nuclear Proteins; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Serpins; Transfection; Tumor Cells, Cultured; Viral Proteins | 1997 |
A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Topics: Antigens, Surface; Antineoplastic Agents, Phytogenic; Base Sequence; DNA Nucleotidyltransferases; DNA Primers; DNA, Neoplasm; Etoposide; Exons; Gene Deletion; Genes, RAG-1; Humans; Hypoxanthine Phosphoribosyltransferase; Infant, Newborn; Leukemia, T-Cell; Microscopy, Electron; Molecular Sequence Data; Receptors, Antigen, T-Cell; Recombination, Genetic; Tumor Cells, Cultured; VDJ Recombinases | 1998 |
Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 1; Caspase 3; Caspase Inhibitors; Cell Size; Chromatin; Cysteine Proteinase Inhibitors; Etoposide; Leukemia, T-Cell; Membrane Lipids; Microscopy, Electron; Neoplasm Proteins; Oligopeptides; Poly(ADP-ribose) Polymerases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Tumor Cells, Cultured | 1999 |
[The role of mitochondria in apoptosis in U937 and Molt-4 cells: difference in order of mitochondrial membrane potential (delta psi m) reduction and interleukin-1 beta-converting enzyme (ICE) on signal transduction pathway in each cell type].
Topics: Apoptosis; Caspase 1; DNA Fragmentation; Etoposide; Humans; Leukemia, Myeloid; Leukemia, T-Cell; Membrane Potentials; Mitochondria; Signal Transduction; Tumor Cells, Cultured; U937 Cells | 1999 |
A brief intensive chemotherapy in T-prolymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Pentostatin; Prognosis; T-Lymphocyte Subsets; Transplantation, Autologous; Vincristine | 2000 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Statistics, Nonparametric; Teniposide; Thioguanine; Vincristine | 2000 |
Drug resistance does not correlate with resistance to Fas-mediated apoptosis.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; fas Receptor; Humans; Immunoglobulin M; Leukemia, T-Cell; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured | 2001 |
Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Etoposide; Leukemia, T-Cell; Methotrexate; Mice; Tumor Cells, Cultured; Vincristine | 2001 |
[Oral administration of etoposide therapy in refractory malignant lymphoma and adult T cell lymphoma].
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged | 1991 |
[A case of chronic adult T-cell leukemia benefited by small doses of MEPP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Leukemia, T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone; Skin | 1988 |